[1] Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol, 2008, 586(1): 113–121.
[2] 张涛, 张传芳, 金锋, 王沥. 体能相关基因研究的新进展. 遗传, 2004, 26(2): 219–226.
[3] 张传芳, 王沥, 张涛, 金锋. 人类的体能与遗传. 遗传学报, 2004, 31(3): 317–324.
[4] Ahmetov II, Williams AG, Popov DV, Lyubaeva EV, Ha-kimullina AM, Fedotovskaya ON, Mozhayskaya IA, Vi-nogradova OL, Astratenkova IV, Montgomery HE, Rogozkin VA. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and re-lated phenotypes. Human Genet, 2009, 126(6): 751–761.
[5] Trent RJ, Yu B. The future of genetic research in exercise science and sports medicine. Med Sport Sci, 2009, 54: 187–195.
[6] Bray MS, Hagberg JM, Pérusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C. The human gene map for per-formance and health-related fitness phenotypes: The 2006-2007 update. Med Sci Sports Exerc, 2009, 41(1): 35–73.
[7] Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acy-lated peptide from stomach. Nature, 1999, 402(6762): 656–660.
[8] Nogueiras R, Perez-Tilve D, Wortley KE, Tschöp M. Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets, 2006, 5(3): 335–343.
[9] Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K. Ghrelin strongly stimulates growth hormone (GH) release in humans. J Clin Endocr Metab, 2000, 85(12): 4908–4911.
[10] Vestergaard ET, Dall R, Lange KHW, Kjaer M, Christiansen JS, Jorgensen JOL. The ghrelin response to exercise before and after growth hormone administration. J Clin Endocrinol Metab, 2007, 92(1): 297–303.
[11] Dall R, Kanaley J, Hansen TK, Møller N, Christiansen JS, Hosoda H, Kangawa K, Jørgensen JO. Plasma ghrelin lev-els during exercise in healthy subjects and in growth hor-mone-deficient patients. Eur J Endocrinol, 2002, 147(1): 65–70.
[12] Gibney J, Healy ML, Sönksen PH. The growth hor-mone/insulin-like growth factor-I axis in exercise and sport. Endocr Rev, 2007, 28(6): 603–624.
[13] Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S. The in-fluence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev, 2006, 27(3): 287–317.
[14] Sjögren K, Leung KC, Kaplan W, Gardiner-Garden M, Gibney J, Ho KKY. Growth hormone regulation of meta-bolic gene expression in muscle: a microarray study in hypopituitary men. Am J Physiol Endocrinol Metab, 2007, 293(1): E364–E371.
[15] López-Alarcón M, Hunter GR, Gower BA, Fernández JR. IGF-I polymorphism is associated with lean mass, exercise economy, and exercise performance among premenopausal women. Arch Med Res, 2007, 38(1): 56–63.
[16] Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu HY, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron, 2003, 37(4): 649–661.
[17] Katugampola SD, Pallikaros Z, Davenport AP. [125I-His9]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up-regulation of receptors with athersclerosis. Br J Pharmacol, 2001, 134(1): 143–149.
[18] Wiley KE, Davenport AP. Comparison of the effects of atherosclerosis and nitrate therapy on responses to nitric oxide and endothelin-1 in human arteries in vitro. J Cl
